{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:13:54Z","timestamp":1790342034333,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["991862"],"award-info":[{"award-number":["991862"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.bioorg.2025.108879","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:55:49Z","timestamp":1755500149000},"page":"108879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Novel imidazolyl-hydroxamic acid Schiff base scaffold derivatives as histone deacetylase inhibitors: Design, synthesis, and biological assessment"],"prefix":"10.1016","volume":"164","author":[{"given":"Zahra","family":"Jamshidi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalil","family":"Abnous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razieh","family":"Ghodsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mohammad","family":"Taghdisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzin","family":"Hadizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.bioorg.2025.108879_bb0005","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/cncr.33587","article-title":"The ever-increasing importance of cancer as a leading cause of premature death worldwide","volume":"127","author":"Bray","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.bioorg.2025.108879_bb0010","first-page":"209","article-title":"Global Cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108879_bb0015","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.drudis.2016.11.014","article-title":"Target-based approaches for the discovery of new antimycobacterial drugs","volume":"22","author":"Borsari","year":"2017","journal-title":"Drug Discov. Today"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108879_bb0020","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41392-024-02080-z","article-title":"Cyclin-dependent protein kinases and cell cycle regulation in biology and disease","volume":"10","author":"Pellarin","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.bioorg.2025.108879_bb0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/sj.cr.7310149","article-title":"HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics","volume":"17","author":"Gallinari","year":"2007","journal-title":"Cell Res."},{"issue":"23","key":"10.1016\/j.bioorg.2025.108879_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232315189","article-title":"Many functions of telomerase components: certainties, doubts, and inconsistencies","volume":"23","author":"Udroiu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108879_bb0035","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13072-022-00467-2","article-title":"A standardized nomenclature for mammalian histone genes","volume":"15","author":"Seal","year":"2022","journal-title":"Epigenetics Chromatin"},{"issue":"5","key":"10.1016\/j.bioorg.2025.108879_bb0040","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/14789450.2.5.719","article-title":"Histone structure and nucleosome stability","volume":"2","author":"Mari\u00f1o-Ram\u00edrez","year":"2005","journal-title":"Expert Rev. Proteomics"},{"issue":"1","key":"10.1016\/j.bioorg.2025.108879_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1756-8935-1-9","article-title":"Chromatin structure and DNA damage repair","volume":"1","author":"Dinant","year":"2008","journal-title":"Epigenetics Chromatin"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108879_bb0050","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1016\/j.apsb.2023.02.007","article-title":"Targeting histone deacetylases for cancer therapy: trends and challenges","volume":"13","author":"Liang","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.108879_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bonr.2017.08.001","article-title":"Histone deacetylases and their roles in mineralized tissue regeneration","volume":"7","author":"Huynh","year":"2017","journal-title":"Bone Rep."},{"key":"10.1016\/j.bioorg.2025.108879_bb0060","article-title":"The roles of histone deacetylases and their inhibitors in Cancer therapy","volume":"8","author":"Li","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"issue":"4","key":"10.1016\/j.bioorg.2025.108879_bb0065","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s13311-013-0226-1","article-title":"Small molecule inhibitors of zinc-dependent histone deacetylases","volume":"10","author":"Wagner","year":"2013","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.bioorg.2025.108879_bb0070","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3390\/ph18040577","article-title":"Drug discovery for histone deacetylase inhibition: past, present and future of zinc-binding groups","volume":"18","author":"Pires","year":"2025","journal-title":"Pharmaceuticals"},{"issue":"13","key":"10.1016\/j.bioorg.2025.108879_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241311044","article-title":"Design, synthesis, and biological evaluation of novel Quinazolin-4(3H)-one-based histone deacetylase 6 (HDAC6) inhibitors for anticancer activity","volume":"24","author":"Khetmalis","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.bioorg.2025.108879_bb0080","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4155\/fmc.13.141","article-title":"Therapeutic potential of isoform selective HDAC inhibitors for the treatment of schizophrenia","volume":"5","author":"We\u00efwer","year":"2013","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108879_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010209","article-title":"Targeting histone deacetylases: opportunities for Cancer treatment and chemoprevention","volume":"14","author":"Ruzic","year":"2022","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108879_bb0090","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3184\/174751916X14664437565774","article-title":"Efficient one-pot three-component synthesis of novel spiro(indoline-3,7\u2032-thiazolo[3,2-a]pyrimidine) derivatives","volume":"40","author":"Jamshidi","year":"2016","journal-title":"J. Chem. Res."},{"key":"10.1016\/j.bioorg.2025.108879_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.105162","article-title":"Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents","volume":"115","author":"Shakour","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108879_bb0100","first-page":"451","article-title":"Synthesis of novel 4-[1-(4-fluorobenzyl)-5-imidazolyl] Dihydropyridines and studying their effects on rat blood pressure","volume":"14","author":"Mohajeri","year":"2011","journal-title":"Iran. J. Basic Med. Sci."},{"key":"10.1016\/j.bioorg.2025.108879_bb0105","doi-asserted-by":"crossref","first-page":"181","DOI":"10.14233\/ajchem.2019.21621","article-title":"Synthesis,characterization and assessment of local anesthetic activity of some benzohydroxamic acids","volume":"31","author":"Aldeen","year":"2019","journal-title":"Asian J. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108879_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100423","article-title":"Synthesis and antinociceptive activity of four 1H-isoindolo-1,3(2H)-diones","volume":"355","author":"Dziubina","year":"2022","journal-title":"Arch Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2025.108879_bb0115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2019.03.006","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors","volume":"144","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"16","key":"10.1016\/j.bioorg.2025.108879_bb0120","doi-asserted-by":"crossref","first-page":"18341","DOI":"10.1021\/acsomega.4c00200","article-title":"Investigating the mechanistic of Danhong injection in brain damage caused by cardiac I\/R injury via bioinformatics, computer simulation, and experimental validation","volume":"9","author":"Wang","year":"2024","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.bioorg.2025.108879_bb0125","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2174\/1573406417666210608143128","article-title":"Potential biological targets prediction, ADME profiling, and molecular docking studies of novel steroidal products from Cunninghamella blakesleana","volume":"18","author":"Yousuf","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108879_bb0130","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.672503","article-title":"Novel 2-Hydroselenonicotinonitriles and Selenopheno[2, 3-b]pyridines: efficient synthesis, molecular docking-DFT modeling, and antimicrobial assessment","volume":"9","author":"Abdellattif","year":"2021","journal-title":"Front. Chem."},{"issue":"12","key":"10.1016\/j.bioorg.2025.108879_bb0135","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8120568","article-title":"Molecular docking simulations on histone deacetylases (HDAC)-1 and \u22122 to investigate the flavone binding","volume":"8","author":"Scafuri","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.108879_bb0140","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2017.03.024","article-title":"Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents","volume":"132","author":"Abdizadeh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2025.108879_bb0145","doi-asserted-by":"crossref","first-page":"548","DOI":"10.6026\/97320630010548","article-title":"VMD-SS: a graphical user interface plug-in to calculate the protein secondary structure in VMD program","volume":"10","author":"Yahyavi","year":"2014","journal-title":"Bioinformation"},{"issue":"6","key":"10.1016\/j.bioorg.2025.108879_bb0150","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1007\/s12032-024-02396-4","article-title":"Phytochemical profiling, cytotoxic, anti-migration, and anti-angiogenic potential of phenolic-rich fraction from Peganum harmala: in vitro and in ovo studies","volume":"41","author":"Kemel","year":"2024","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bioorg.2025.108879_bb0155","article-title":"Engineering extracellular vesicles derived from lemons for delivering chemotherapeutic drug employing periostin targeting","volume":"99","author":"Jamshidi","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.bioorg.2025.108879_bb0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/978-1-61779-080-5_20","article-title":"Cell sensitivity assays: the MTT assay","volume":"731","author":"van Meerloo","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"19","key":"10.1016\/j.bioorg.2025.108879_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27196724","article-title":"Development of semisynthetic apoptosis-inducing agents based on natural phenolic acids scaffold: design, synthesis and in-vitro biological evaluation","volume":"27","author":"Ezzat","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.bioorg.2025.108879_bb0170","doi-asserted-by":"crossref","first-page":"895","DOI":"10.2174\/1573406418666220210111458","article-title":"Synthesis, anticancer activities, and mechanism of N-heptyl-containing Biguanide derivatives","volume":"18","author":"Wang","year":"2022","journal-title":"Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108879_bb0175","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2025.108879_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137749","article-title":"Design, synthesis, biological evaluation and molecular docking study of novel chalcone-based hydroxamic acids possessing a central 2, 4-dimethy pyrrole linker as potential HDAC (histone deacetylase) inhibitors and anticancer agents","volume":"1305","author":"Yousefian","year":"2024","journal-title":"J. Mol. Struct."},{"issue":"5","key":"10.1016\/j.bioorg.2025.108879_bb0185","doi-asserted-by":"crossref","first-page":"914","DOI":"10.2174\/1871520621666210901102425","article-title":"Novel Suberoylanilide Hydroxamic acid analogs inhibit angiogenesis and induce apoptosis in breast Cancer cells","volume":"22","author":"Moku","year":"2022","journal-title":"Anti Cancer Agents Med. Chem."},{"issue":"15","key":"10.1016\/j.bioorg.2025.108879_bb0190","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.1021\/jm200577a","article-title":"Discovery of a tetrahydroisoquinoline-based hydroxamic acid derivative (ZYJ-34c) as histone deacetylase inhibitor with potent oral antitumor activities","volume":"54","author":"Zhang","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108879_bb0195","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ejmech.2019.06.054","article-title":"Design, synthesis and in vitro evaluation of 6-amide-2-aryl benzoxazole\/benzimidazole derivatives against tumor cells by inhibiting VEGFR-2 kinase","volume":"179","author":"Yuan","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.108879_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108886","article-title":"5-(3,4,5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) targets tubulin and DNA to induce anticancer activity and overcome multidrug resistance in colorectal cancer cells","volume":"315","author":"Bai","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108879_bb0205","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1091581809352111","article-title":"Nonclinical safety assessment of the histone deacetylase inhibitor vorinostat","volume":"29","author":"Kerr","year":"2010","journal-title":"Int. J. Toxicol."},{"issue":"1","key":"10.1016\/j.bioorg.2025.108879_bb0210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12951-022-01374-0","article-title":"Titanium nanosheet as robust and biosafe drug carrier for combined photochemo cancer therapy","volume":"20","author":"Yuan","year":"2022","journal-title":"J. Nanobiotechnol."},{"issue":"7","key":"10.1016\/j.bioorg.2025.108879_bb0215","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.chembiol.2015.06.011","article-title":"Design and characterization of novel EphA2 agonists for targeted delivery of chemotherapy to Cancer cells","volume":"22","author":"Wu","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.108879_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121892","article-title":"Dual-targeted and controlled release delivery of doxorubicin to breast adenocarcinoma: in vitro and in vivo studies","volume":"623","author":"Jamshidi","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.bioorg.2025.108879_bb0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.lungcan.2022.10.002","article-title":"IL-9 stimulates an anti-tumor immune response and facilitates immune checkpoint blockade in the CMT167 mouse model","volume":"174","author":"Feng","year":"2022","journal-title":"Lung Cancer"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500759X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520682500759X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T05:48:03Z","timestamp":1757656083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520682500759X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":45,"alternative-id":["S004520682500759X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108879","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel imidazolyl-hydroxamic acid Schiff base scaffold derivatives as histone deacetylase inhibitors: Design, synthesis, and biological assessment","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.108879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108879"}}